Remove tag recalls
article thumbnail

STAT+: Pharmalittle: New York officials press pharmacy chains over abortion pill; Sanders pushes bill for $20 insulin cap

STAT News

This is, you may recall, our treasured signal to daydream about weekend plans. And so, another working week will soon draw to a close. Not a moment too soon, yes? Our agenda is rather abbreviated this time around due to a Woodstock-like gathering for health journos. But neither factor has much effect, the studies concluded.

Insulin 96
article thumbnail

Establishing Safer Food Supply Chains with Blockchain and IoT

XTalks

Recalls and subsequent losses in sales can be financially detrimental to food companies. To help increase the safety of supply chains and reduce recalls and fines, supply chain information must be more trustworthy. When it comes to foodborne illness, E. coli and Salmonella outbreaks occur year-round.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds August 25, 2023: Pragmatic Trial of an EHR Application to Display Real-time PRO Data: Successes and Challenges (Gabriela Schmajuk, MD, MS)

Rethinking Clinical Trials

Was patient recall about past visits accurate several months later? Tags #pctGR, @Collaboratory1 The post Grand Rounds August 25, 2023: Pragmatic Trial of an EHR Application to Display Real-time PRO Data: Successes and Challenges (Gabriela Schmajuk, MD, MS) appeared first on Rethinking Clinical Trials.

Trials 141
article thumbnail

The FDA and Aduhelm: WTF?

World of DTC Marketing

Recall that with this drug, about 30–40 percent of study participants experienced either brain swelling or bleeding. Not to mention the $56,000 annual price tag. Aduhelm joins a group of drugs that potentially leave patients worse off and much poorer for it.

Drugs 218
article thumbnail

Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’

The Pharma Data

Pfizer’s Hospira recalls hospital anesthetics, flags ‘moderate to high severity’ safety risks ( Fierce ). AbbVie’s Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along ( Fierce ). Medtech. Government & Regulatory.

article thumbnail

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

healthcare reform or legislation or any significant spending reductions or cost controls affecting Medicare, Medicaid or other publicly funded or subsidized health programs or changes in the tax treatment of employer-sponsored health insurance that may be implemented; U.S. View source version on businesswire.com : [link]. Amy Rose 212.733.7410.